Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: Long-term prognosis after five years. [electronic resource]
Producer: 20030606Description: 127-31 p. digitalISSN:- 1021-335X
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Double-Blind Method
- Doxorubicin -- administration & dosage
- Female
- Humans
- Incidence
- Injections, Intraperitoneal
- Macrophage Colony-Stimulating Factor -- adverse effects
- Middle Aged
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
- Survival Rate
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.